For Riley Cordeau, completing a summer internship at a Boston-area biotechnology research company on the cusp of his graduation this year was like using a GPS from the UMass Amherst campus to a place he has never been before. The turn-by-turn directi
/PRNewswire/ Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective September 1, 2023, the Compensation Committee of Blueprint.
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Equities research analysts at HC Wainwright raised their Q3 2023 earnings per share (EPS) estimates for Blueprint Medicines in a research note issued to investors on Thursday, August 3rd. HC Wainwright analyst A. Fein now expects that the biotechnology company will post earnings of ($2.21) per share […]